Your browser doesn't support javascript.
loading
Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas.
Kim, Jue Young; Kim, Jinsun; Bazarsad, Shadavlonjid; Cha, In-Ho; Cho, Sung-Won; Kim, Jin.
  • Kim JY; Department of Oral Pathology, Oral Cancer Research Institute, Seoul, Republic of Korea.
  • Kim J; Division of Anatomy and Developmental Biology, Department of Oral Biology, Seoul, Republic of Korea.
  • Bazarsad S; Department of Oral Pathology, Oral Cancer Research Institute, Seoul, Republic of Korea.
  • Cha IH; Department of Oral and Maxillofacial Surgery, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea.
  • Cho SW; Division of Anatomy and Developmental Biology, Department of Oral Biology, Seoul, Republic of Korea.
  • Kim J; Department of Oral Pathology, Oral Cancer Research Institute, Seoul, Republic of Korea.
Oral Dis ; 25(4): 1158-1168, 2019 May.
Article en En | MEDLINE | ID: mdl-30801855
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ameloblastoma / Neoplasias Maxilomandibulares / Linfoma de Células B / Osteoprotegerina Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ameloblastoma / Neoplasias Maxilomandibulares / Linfoma de Células B / Osteoprotegerina Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article